The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced a strategic collaboration with Microsoft to explore ...

Bringing together the worlds of assistive technology and consumer electronics is becoming increasingly necessary with ever-developing digital technology and communication abilities, for those with ...

A neural interface framework integrating L2 regularization with attention supervision paradigms achieves 96.87% classification accuracy in EEG ...

Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego The round was led by Double Point Ventures, alongside ...

Over the past decade, neurotechnology – the science of connecting technology directly with the brain – has grown at an astonishing pace. This field is developing devices that can monitor or even ...

The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.

SCI Ventures’ investment in Precision reflects the firm's belief in the potential impact of the BCI field. The fund provides not only capital but also deep networks of clinicians, regulatory experts, ...

Brain-computer interface technology has long belonged to the realm of science fiction, but it’s quickly emerging as a real-world innovation with the potential to transform how we live, work and ...

Australia has invested $54 million in Melbourne-born brain-computer interface company Synchron, the federal government’s National Reconstruction Fund Corporation (NRFC) announced on Thursday.

Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...